The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
Blog |
NICE has updated how it values quality of life - the move from 3L to 5L
Blog |
The Health Data Research Service: a once-in-a-generation chance to lead the world
Blog |
The NHS Federated Data Platform, the Single Patient Record and the Health Data Research Service – what are they, and how do they relate to the UK’s pharmaceutical industry?
Blog |
New pre-clinical translational models hub to accelerate development of human-relevant models for medicines discovery
Brought Together campaign
The innovative pharmaceutical industry in the UK exists to transform and improve lives through research, development and access to new medicines and vaccines.
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Events
NICE/DTSU/ABPI Masterclass: Evidence Synthesis for NICE submissions
The NICE/DTSU/ABPI Masterclasses are unique in being focused solely on the specific requirements of NICE and its Appraisal Committees and on the challenges associated with key areas of evidence generation and methodology.
SAVE THE DATE - ABPI Industry Summit 2026
Registration opens soon! This event, for ABPI members and invited guests, will assess the way industry builds familiarity and trust, and will ask if we need to challenge ourselves to work differently to achieve radical change for patients.
Global Pharma & Biotech Summit
The Global Pharma and Biotech Summit, organised by the Financial Times, brings together the leaders, investors and policymakers shaping the next phase of life sciences. Hear from 60+ expert speakers from organisations including Novartis, GSK, Novo Nordisk, Takeda, Bayer and the Medicines and Healthcare products Regulatory Agency (MHRA) as they explore geopolitical and economic disruption, AI, regulation, market access and the rise of new pharmaceutical innovation hubs.
SAVE THE DATE - ABPI Annual Conference 2027
Save the date for the ABPI Annual Conference 2027, the UK pharmaceutical industry's flagship event bringing together senior leaders, policymakers, clinicians and stakeholders from across the life sciences sector. The conference provides a platform for open dialogue on the issues shaping the future of medicines development, access and innovation in the UK.
Full programme details, speakers and session themes will be announced in due course. Check back for updates, or register your interest to be notified as soon as further information is available.
Economic statistics
£20.39bn
direct Gross Value Added (GVA) [1]
£9.3bn
investment in UK R&D in 2024 [2]
£1 in every £6
invested by the private sector in R&D is invested by the pharmaceutical industry [3]